The world of orphan drugs is at the cusp of a transformation in the post COVID era. In this episode, the team discuss the impact of the pandemic on value demonstration of orphan drugs. In order to be successful, manufacturers of precision medicine will need to focus on carving out a niche for their drugs and support health systems to find the right patient for their treatment at the right time.
The team also explore the role of digital tools such as Artificial Intelligence (AI) and telemedicine in helping drugmakers optimise manufacturing and treatment delivery. This combined with a multi-stakeholder approach will provide the recipe for success for next generation`niche-busters'.
Presenter and Contributor : Akshay Kumar
Other contributors: Richard Wang, Andrea Bernardini and Erfan Akbraian
Producer: Aparna Krishnan
Weekly Roundup: February 28, 2019
Weekly Roundup: February 22, 2019
Weekly Roundup: February 15, 2019
Weekly Roundup: February 1, 2019
Weekly Roundup: January 25, 2019
Weekly Roundup: January 18, 2019
Weekly Roundup: January 11, 2019
Weekly Roundup: December 14, 2018
Weekly Roundup: December 7, 2018
Weekly Roundup: November 30, 2018
Weekly Roundup: November 23, 2018
Weekly Roundup: November 15, 2018
Weekly Roundup: November 9, 2018
Weekly Roundup: November 2, 2018
Weekly Roundup: October 25, 2018
Weekly Roundup: October 18, 2018
Weekly Roundup: October 11, 2018
Weekly Roundup: Oct 5, 2018
Weekly Roundup: Sep 27, 2018
Weekly Roundup: September 20, 2018
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain